Most up-to-date research on "Stroke Partnering 2010-2015" to its huge collection of research reports.
Albany, NY -- (SBWIRE) -- 04/10/2015 -- The Stroke Partnering 2010-2015 report provides understanding and access to the stroke partnering deals and agreements entered into by the worlds leading healthcare companies.
Trends in stroke partnering deals
Top stroke deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type
Browse Detail Report With TOC
The Stroke Partnering 2010-2015 provides understanding and access to the stroke partnering deals and agreements entered into by the worlds leading healthcare companies.
The report provides an analysis of stroke partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors stroke technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.
Request for Sample Report
This data driven report contains over 80 links to online copies of actual stroke deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.
The initial chapters of this report provide an orientation of stroke partnering trends.
Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in partnering since 2010, including a summary of deals by industry sector, stage of development, deal type, and technology type.
Chapter 3 provides an overview of the average deal terms since 2010. The chapter includes deals with a stage of development announced by headline value, upfront value, milestone value and royalty rate. Numerous tables outline financial trends.
Chapter 4 provides an overview of the most active dealmakers, top dealmakers by value, active big pharma and big biotech dealmakers including contract documents where available.
Chapter 5 provides a comprehensive directory of partnering deals signed and announced since 2010. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of stroke technologies and products.
For Market Research Latest Reports Visit
Stroke Partnering 2010-2015 is intended to provide the reader with an in-depth understanding and access to stroke trends and structure of deals entered into by leading companies worldwide.
This data driven report includes:
Trends in stroke dealmaking in the biopharma industry since 2010
Access to summary headline, upfront, milestone and royalty data
Access to over 80 stroke deals and contract documents where available
The leading stroke deals by value since 2010
In Stroke Partnering 2010-2015, the available deals are listed by:
Upfront payment value
Royalty rate value
Stage of development at signing
Deal component type
Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Competitor Analysis: Therapeutic Antibodies 2015 - Biosimilars & Biosuperiors
Competitor Analysis: Therapeutic Antibodies 2015: Biosimilars & Biosuperiors This Competitive Intelligence Report about Therapeutic Antibodies 2015: Biosimilars & Biosuperiors provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies in the market, in the pipeline as next generation products and as biosimilar versions as of April...
Global Melanoma Therapeutics Market 2015-2019
About Melanoma According to Melanoma Research Foundation, melanoma is usually, but not always, a cancer of the skin. Melanoma is defined as a cancer that occurs in melanocytes (cells that make the pigment melanin). Chest and back in men and legs in women are the most likely parts to be affected with melanoma. CM, MM, and OM are the three major categories of melanoma....
Browse All Reports in Therapeutic Area Category
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
Toll Free: 866-997-4948
90 State Street, Suite 700
Albany, NY 12207